Get the Stockscreener App
2.37
2.16%
0.05
Nkarta Inc stock is traded at $2.37, with a volume of 746.32K.
It is up +2.16% in the last 24 hours and up +13.94% over the past month.
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.
See More
Previous Close:
$2.32
Open:
$2.32
24h Volume:
746.32K
Relative Volume:
1.47
Market Cap:
$168.33M
Revenue:
-
Net Income/Loss:
$-117.50M
P/E Ratio:
-0.9875
EPS:
-2.4
Net Cash Flow:
$-114.31M
1W Performance:
+1.72%
1M Performance:
+13.94%
6M Performance:
+15.61%
1Y Performance:
-53.98%
1-Day Range:
$2.30
$2.44
1-Week Range:
$2.225
$2.495
52-Week Range:
$1.31
$6.6279
Nkarta Inc Stock (NKTX) Company Profile
Name
Nkarta Inc
Sector
Industry
Phone
(925) 407-1049
Address
1150 VETERANS BOULEVARD, SOUTH SAN FRANCISCO
Compare NKTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NKTX
Nkarta Inc
|
2.37 | 166.91M | 0 | -117.50M | -114.31M | -2.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Nkarta Inc Stock (NKTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-15-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-09-24 | Initiated | Rodman & Renshaw | Buy |
| Aug-14-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| Mar-22-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-22-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Oct-10-22 | Initiated | Canaccord Genuity | Buy |
| Jul-28-22 | Initiated | Needham | Buy |
| Jul-18-22 | Initiated | SVB Leerink | Outperform |
| Mar-11-22 | Initiated | Raymond James | Outperform |
| Mar-08-22 | Initiated | H.C. Wainwright | Buy |
| Jan-06-22 | Initiated | William Blair | Outperform |
| Nov-18-21 | Initiated | SMBC Nikko | Outperform |
| Jul-16-21 | Initiated | Oppenheimer | Outperform |
| Aug-04-20 | Initiated | Cowen | Outperform |
| Aug-04-20 | Initiated | Evercore ISI | Outperform |
| Aug-04-20 | Initiated | Mizuho | Buy |
| Aug-04-20 | Initiated | Stifel | Buy |
View All
Nkarta Inc Stock (NKTX) Latest News
Why Nkarta Inc. is moving todayEntry Point & Scalable Portfolio Growth Ideas - Newser
Using data tools to time your Nkarta Inc. exitJuly 2025 Decliners & Consistent Return Strategy Ideas - Newser
Statistical indicators supporting Nkarta Inc.’s strengthJuly 2025 Short Interest & Low Risk High Reward Ideas - Newser
Can a trend reversal in Nkarta Inc. lead to recoveryWeekly Stock Report & High Accuracy Trade Alerts - Newser
Custom watchlist performance reports with Nkarta Inc.Market Risk Report & Pattern Based Trade Signal System - Newser
Quantitative breakdown of Nkarta Inc. recent moveMarket Sentiment Report & Growth Focused Stock Reports - Newser
What recovery options are there for Nkarta Inc.Trade Volume Report & Low Risk Profit Maximizing Plans - Newser
Applying chart zones and confluence areas to Nkarta Inc.Market Sentiment Report & Technical Pattern Alert System - Newser
Can volume confirm reversal in Nkarta Inc.2025 Support & Resistance & Weekly Momentum Picks - Newser
Is Nkarta Inc. showing signs of accumulation2025 Trade Ideas & Weekly Setup with ROI Potential - Newser
Building trade automation scripts for Nkarta Inc.2025 Buyback Activity & Daily Profit Focused Screening - Newser
Will a bounce in Nkarta Inc. offer an exitWeekly Risk Summary & Real-Time Chart Pattern Alerts - Newser
Institutional scanner results for Nkarta Inc.2025 Fundamental Recap & High Accuracy Swing Trade Signals - Newser
Analyzing recovery setups for Nkarta Inc. investorsMarket Weekly Review & AI Powered Buy/Sell Recommendations - Newser
When is the best time to exit Nkarta Inc.Portfolio Risk Report & Safe Swing Trade Setup Alerts - Newser
How Nkarta Inc. stock performs during market volatilityWeekly Gains Report & Fast Exit and Entry Trade Guides - Newser
Can Nkarta Inc. rally from current levels2025 Buyback Activity & Free Safe Capital Growth Stock Tips - Newser
Is Nkarta Inc. trending in predictive chart modelsBreakout Watch & Daily Stock Trend Watchlist - Newser
Combining price and volume data for Nkarta Inc.Quarterly Risk Review & Weekly Stock Breakout Alerts - Newser
Applying Wyckoff theory to Nkarta Inc. stockTrade Performance Summary & Low Drawdown Investment Ideas - Newser
Leerink Partnrs Brokers Boost Earnings Estimates for Nkarta - Defense World
Stifel Nicolaus Lowers Nkarta (NASDAQ:NKTX) Price Target to $12.00 - Defense World
Wall Street Zen Upgrades Nkarta (NASDAQ:NKTX) to “Hold” - Defense World
HC Wainwright Comments on Nkarta’s Q3 Earnings (NASDAQ:NKTX) - Defense World
Detecting price anomalies in Nkarta Inc. with AIPortfolio Growth Summary & Daily Technical Stock Forecast Reports - Newser
Custom watchlist performance reports with Nkarta IncEarnings Overview Report & Daily Stock Trend Reports - Newser
Nkarta price target lowered to $12 from $14 at Stifel - MSN
What’s the MACD signal for Nkarta Inc.2025 Momentum Check & Weekly Momentum Stock Picks - newsyoung.net
Historical volatility pattern of Nkarta Inc. visualizedJuly 2025 Big Picture & Reliable Entry Point Trade Alerts - Newser
Nkarta Inc Stock (NKTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Nkarta Inc Stock (NKTX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Shook David | See Remarks |
Jan 15 '25 |
Sale |
2.20 |
8,638 |
19,004 |
190,955 |
| Levin Alyssa | See Remarks |
Jan 15 '25 |
Sale |
2.20 |
5,838 |
12,844 |
102,662 |
| Brandenberger Ralph | Chief Technical Officer |
Jan 15 '25 |
Sale |
2.20 |
7,447 |
16,383 |
124,796 |
| HASTINGS PAUL J | Chief Executive Officer |
Jan 15 '25 |
Sale |
2.20 |
17,378 |
38,232 |
319,859 |
| Hager Alicia J. | Chief Legal Officer |
Jan 15 '25 |
Sale |
2.20 |
9,584 |
21,085 |
146,735 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):